Financial reports
ARS
2023 FY
Annual report to shareholders
5 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Results of Operations and Financial Condition
17 Apr 24
8-K
Results of Operations and Financial Condition
12 Mar 24
8-K
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance
29 Feb 24
8-K
Entry into a Material Definitive Agreement
23 Feb 24
8-K
Results of Operations and Financial Condition
8 Feb 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Results of Operations and Financial Condition
15 Nov 23
8-K
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
8 Nov 23
8-K
Other Events
2 Oct 23
8-K
Results of Operations and Financial Condition
25 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
23 Jun 23
424B5
Prospectus supplement for primary offering
12 May 23
424B5
Prospectus supplement for primary offering
11 May 23
S-8
Registration of securities for employees
27 Apr 22
424B3
Prospectus supplement
19 Jan 22
S-3
Shelf registration
17 Dec 21
424B5
Prospectus supplement for primary offering
5 Nov 21
424B5
Prospectus supplement for primary offering
3 Nov 21
S-8
Registration of securities for employees
1 Nov 21
S-8
Registration of securities for employees
23 Nov 20
Proxies
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
8 May 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
25 Mar 22
DEFA14A
Additional proxy soliciting materials
7 May 21
DEF 14A
Definitive proxy
29 Apr 21
PRE 14A
Preliminary proxy
19 Apr 21
Other
CT ORDER
Confidential treatment order
22 Feb 23
UPLOAD
Letter from SEC
30 Jan 23
CORRESP
Correspondence with SEC
27 Jan 23
CORRESP
Correspondence with SEC
6 Jan 23
UPLOAD
Letter from SEC
12 Dec 22
CORRESP
Correspondence with SEC
5 Dec 22
UPLOAD
Letter from SEC
1 Nov 22
EFFECT
Notice of effectiveness
19 Jan 22
CORRESP
Correspondence with SEC
13 Jan 22
UPLOAD
Letter from SEC
28 Dec 21
Ownership
4
Muthusamy Shanmugam
22 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
18 Apr 24
4
Muthusamy Shanmugam
17 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Meredith Cook
15 Apr 24
4
James G. Marken
11 Apr 24
4
STEPHEN P. CAREY
11 Apr 24